Neuromuscular Diseases clinical trials at UC Health

• Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy

  open to eligible males ages 5 years and up

  This study is a long-term study of ataluren in participants with nonsense mutation Duchenne muscular dystrophy.

  at UC Davis UCSF

Last updated: September 2, 2020